{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:10:20Z","timestamp":1787163020080,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objective<\/jats:title>\n                    <jats:p>Cancer patients treated with palliative intent often report anxiety. Anxiety is associated with dyspnoea, cancer pain, and reduced quality of life. Limited knowledge on variability and treatment effects warranted exploring factors associated with improvement in anxiety for hospitalised palliative cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study is a cross-sectional secondary analysis. All patients admitted to an acute palliative care unit for one year were assessed and 164 patients satisfied the study inclusion criteria. The patients reported self-registered symptom intensities using the 11-point numeric rating scale. Demographic variables, patient reports, and medical management were analysed for associations with anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At admission, 37.8% of the patients reported moderate or severe anxiety, and of these 43.6% used benzodiazepines. The corresponding numbers for benzodiazepine use were 35.1% and 24.4% for patients with mild and no anxiety, respectively. Of all patients, 26.8% reported improved anxiety during their hospital stay. More patients with moderate or severe anxiety at admission reported improved anxiety during hospitalisation (50.0%) compared to the corresponding patients with mild anxiety (22.8%). Patients with moderate or severe anxiety reported less improvement in pain compared to patients with mild anxiety. Improved dyspnoea was the only factor statistically associated with improvement in anxiety, both for patients reporting mild anxiety and moderate and severe anxiety. Thirty-seven-point-1% of patients with moderate or severe anxiety at admission received no benzodiazepine treatment during the hospital stay. Patients receiving midazolam had more anxiety at admission, were younger, and had poorer performance status. Median dose and interquartile range [IQR] of midazolam in these patients were 2\u00a0mg\/24\u00a0h [IQR: 2.0\u20136.0].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Improved dyspnoea was associated with reduced anxiety; however, the use of benzodiazepines was not.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-025-01687-5","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:46:59Z","timestamp":1741844819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emergency palliative cancer care: anxiety and midazolam"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6730-5224","authenticated-orcid":false,"given":"Morten","family":"Tranung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2565-8437","authenticated-orcid":false,"given":"Tora S.","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-3778","authenticated-orcid":false,"given":"Erik Torbj\u00f8rn","family":"L\u00f8hre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3921-6354","authenticated-orcid":false,"given":"Morten","family":"Thronaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-2481","authenticated-orcid":false,"given":"Michael Due","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"9","key":"1687_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/JCO.2010.30.7173","volume":"29","author":"H Seow","year":"2011","unstructured":"Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, et al. Trajectory of performance status and symptom scores for patients with Cancer during the last six months of life. J Clin Oncol. 2011;29(9):1151\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1687_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SCCM Teunissen","year":"2007","unstructured":"Teunissen SCCM, Wesker W, Kruitwagen C, de Haes HCJM, Voest EE, de Graeff A. Symptom Prevalence in patients with Incurable Cancer: a systematic review. J Pain Symptom Manag. 2007;34(1):94\u2013104.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"1687_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/02841869209108179","volume":"31","author":"P Strang","year":"1992","unstructured":"Strang P. Emotional and social aspects of Cancer Pain. Acta Oncol. 1992;31(3):323\u20136.","journal-title":"Acta Oncol"},{"issue":"5","key":"1687_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s40265-018-0879-5","volume":"78","author":"S Mercadante","year":"2018","unstructured":"Mercadante S. Episodic breathlessness in patients with Advanced Cancer: characteristics and management. Drugs. 2018;78(5):543\u20137.","journal-title":"Drugs"},{"issue":"1","key":"1687_CR5","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1093\/oncolo\/oyad211","volume":"29","author":"D Sim\u00e3o","year":"2023","unstructured":"Sim\u00e3o D, Barata PC, Alves M, Papoila AL, Oliveira S, Lawlor P. Symptom clusters in patients with Advanced Cancer: a prospective longitudinal cohort study to Examine their Stability and Prognostic significance. Oncologist. 2023;29(1):e152\u201363.","journal-title":"Oncologist"},{"issue":"6","key":"1687_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1191\/0269216303pm781oa","volume":"17","author":"E Smith","year":"2003","unstructured":"Smith E, Gomm S, Dickens C. Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med. 2003;17(6):509\u201313.","journal-title":"Palliat Med"},{"issue":"4","key":"1687_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1017\/S147895152200116X","volume":"21","author":"A Gonzalez-Ling","year":"2023","unstructured":"Gonzalez-Ling A, Galindo V\u00e1zquez O, Espinoza Bello M, Robles R, Rasc\u00f3n-Gasca ML, Lara-Mej\u00eda L, et al. Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer. Palliat Support Care. 2023;21(4):608\u201315.","journal-title":"Palliat Support Care"},{"issue":"1","key":"1687_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12904-017-0245-5","volume":"16","author":"N Atkin","year":"2017","unstructured":"Atkin N, Vickerstaff V, Candy B. Worried to death\u2019: the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians. BMC Palliat Care. 2017;16(1):69.","journal-title":"BMC Palliat Care"},{"issue":"12","key":"1687_CR9","doi-asserted-by":"publisher","first-page":"e0260921","DOI":"10.1371\/journal.pone.0260921","volume":"16","author":"PK Palmer","year":"2021","unstructured":"Palmer PK, Wehrmeyer K, Florian MP, Raison C, Idler E, Mascaro JS. The prevalence, grouping, and distribution of stressors and their association with anxiety among hospitalized patients. PLoS ONE. 2021;16(12):e0260921.","journal-title":"PLoS ONE"},{"key":"1687_CR10","doi-asserted-by":"crossref","unstructured":"Salt S, Mulvaney CA, Preston NJ. Drug therapy for symptoms associated with anxiety in adult palliative care patients. Cochrane Database Syst Reviews. 2017(5).","DOI":"10.1002\/14651858.CD004596.pub3"},{"issue":"11","key":"1687_CR11","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1007\/s00520-021-06248-z","volume":"29","author":"M Thronaes","year":"2021","unstructured":"Thronaes M, Lohre ET, Kvikstad A, Brenne E, Norvaag R, Aalberg KO, et al. Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study. Support Care Cancer. 2021;29(11):6595\u2013603.","journal-title":"Support Care Cancer"},{"key":"1687_CR12","doi-asserted-by":"publisher","first-page":"263235241989552","DOI":"10.1177\/2632352419895527","volume":"14","author":"E Prommer","year":"2020","unstructured":"Prommer E. Midazolam: an essential palliative care drug. Palliat Care Soc Pract. 2020;14:2632352419895527.","journal-title":"Palliat Care Soc Pract"},{"issue":"2","key":"1687_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jpainsymman.2017.06.010","volume":"55","author":"K Jansen","year":"2018","unstructured":"Jansen K, Haugen DF, Pont L, Ruths S. Safety and Effectiveness of Palliative Drug Treatment in the last days of Life-A systematic literature review. J Pain Symptom Manage. 2018;55(2):508\u201321. e3.","journal-title":"J Pain Symptom Manage"},{"key":"1687_CR14","doi-asserted-by":"publisher","first-page":"108838","DOI":"10.1016\/j.biopha.2019.108838","volume":"114","author":"I Zaporowska-Stachowiak","year":"2019","unstructured":"Zaporowska-Stachowiak I, Szymanski K, Oduah MT, Stachowiak-Szymczak K, Luczak J, Sopata M. Midazolam: safety of use in palliative care: a systematic critical review. Biomed Pharmacother. 2019;114:108838.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1687_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1191\/0269216306pm1151oa","volume":"20","author":"M Henderson","year":"2006","unstructured":"Henderson M, MacGregor E, Sykes N, Hotopf M. The use of benzodiazepines in palliative care. Palliat Med. 2006;20(4):407\u201312.","journal-title":"Palliat Med"},{"issue":"5","key":"1687_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jpainsymman.2019.01.010","volume":"57","author":"SB O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell SB, Nicholson MK, Boland JW. The Association between Benzodiazepines and Survival in patients with Cancer: a systematic review. J Pain Symptom Manage. 2019;57(5):999\u2013e100811.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"1687_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpainsymman.2005.06.009","volume":"31","author":"AH Navigante","year":"2006","unstructured":"Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006;31(1):38\u201347.","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"1687_CR18","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3390\/curroncol31070305","volume":"31","author":"M Tranung","year":"2024","unstructured":"Tranung M, Solheim TS, L\u00f8hre ET, Marsaa K, Faksv\u00e5g Haugen D, Laird B, et al. Midazolam indications and dosing in Palliative Medicine: results from a multinational survey. Curr Oncol. 2024;31(7):4093\u2013104.","journal-title":"Curr Oncol"},{"issue":"Supplement4","key":"1687_CR19","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice guidelines. Ann Oncol. 2018;29(Supplement4):iv166\u201391.","journal-title":"Ann Oncol"},{"key":"1687_CR20","first-page":"CD011008","volume":"3","author":"H Barnes","year":"2016","unstructured":"Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Reviews (Online). 2016;3:CD011008.","journal-title":"Cochrane Database Syst Reviews (Online)"},{"issue":"12","key":"1687_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1200\/JCO.20.03465","volume":"39","author":"D Hui","year":"2021","unstructured":"Hui D, Bohlke K, Bao T, Campbell TC, Coyne PJ, Currow DC, et al. Management of Dyspnea in Advanced Cancer: ASCO Guideline. J Clin Oncol. 2021;39(12):1389\u2013411.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1687_CR22","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.jpainsymman.2022.11.018","volume":"65","author":"ST Simon","year":"2023","unstructured":"Simon ST, Mori M, Ekstr\u00f6m M, Pralong A, Yamaguchi T, Hui D. Should benzodiazepines be used for reducing Dyspnea in patients with Advanced illnesses? J Pain Symptom Manag. 2023;65(3):e219\u201323.","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"1687_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1177\/0269881110367726","volume":"25","author":"A Colasanti","year":"2011","unstructured":"Colasanti A, Rabiner EA, Lingford-Hughes A, Nutt DJ. Opioids and anxiety. J Psychopharmacol. 2011;25(11):1415\u201333.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"1687_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","volume":"53","author":"D Hui","year":"2017","unstructured":"Hui D, Bruera E. The Edmonton Symptom Assessment System 25 years later: past, Present, and future developments. J Pain Symptom Manag. 2017;53(3):630\u201343.","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"1687_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jpainsymman.2012.06.007","volume":"45","author":"WH Oldenmenger","year":"2013","unstructured":"Oldenmenger WH, de Raaf PJ, de Klerk C, van der Rijt CCD. Cut points on 0\u201310 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in Cancer patients: a systematic review. J Pain Symptom Manag. 2013;45(6):1083\u201393.","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"1687_CR26","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/cncr.29970","volume":"122","author":"D Hui","year":"2016","unstructured":"Hui D, Park M, Shamieh O, Paiva CE, Perez-Cruz PE, Muckaden MA, et al. Personalized symptom goals and response in patients with advanced cancer. Cancer. 2016;122(11):1774\u201381.","journal-title":"Cancer"},{"issue":"1","key":"1687_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2354.2012.01369.x","volume":"22","author":"SM Bagha","year":"2013","unstructured":"Bagha SM, Macedo A, Jacks LM, Lo C, Zimmermann C, Rodin G, et al. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Eur J Cancer Care. 2013;22(1):60\u20139.","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"1687_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpainsymman.2009.06.010","volume":"39","author":"D Selby","year":"2010","unstructured":"Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, et al. A single Set of Numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag. 2010;39(2):241\u20139.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"1687_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpainsymman.2012.11.009","volume":"46","author":"JH Kang","year":"2013","unstructured":"Kang JH, Kwon JH, Hui D, Yennurajalingam S, Bruera E. Changes in Symptom Intensity among Cancer patients receiving Outpatient Palliative Care. J Pain Symptom Manag. 2013;46(5):652\u201360.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"1687_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00520-008-0529-7","volume":"17","author":"M Delgado-Guay","year":"2009","unstructured":"Delgado-Guay M, Parsons HA, Li Z, Palmer JL, Bruera E. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer. 2009;17(5):573\u20139.","journal-title":"Support Care Cancer"},{"issue":"5","key":"1687_CR31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jpainsymman.2017.12.489","volume":"55","author":"S Andersson","year":"2018","unstructured":"Andersson S, \u00c5restedt K, Lindqvist O, F\u00fcrst C-J, Br\u00e4nnstr\u00f6m M. Factors Associated with Symptom Relief in End-of-Life Care in Residential Care homes: a National Register-based study. J Pain Symptom Manag. 2018;55(5):1304\u201312.","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"1687_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"1687_CR33","doi-asserted-by":"crossref","unstructured":"Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA et al. Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective, multicenter study. Cancer. 2015.","DOI":"10.1002\/cncr.29437"},{"issue":"15","key":"1687_CR34","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1200\/JCO.2013.52.4611","volume":"32","author":"BL Andersen","year":"2014","unstructured":"Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605\u201319.","journal-title":"J Clin Oncol"},{"key":"1687_CR35","doi-asserted-by":"publisher","first-page":"108838","DOI":"10.1016\/j.biopha.2019.108838","volume":"114","author":"I Zaporowska-Stachowiak","year":"2019","unstructured":"Zaporowska-Stachowiak I, Szyma\u0144ski K, Oduah M-T, Stachowiak-Szymczak K, \u0141uczak J, Sopata M. Midazolam: safety of use in palliative care: a systematic critical review. Biomed Pharmacother. 2019;114:108838.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1687_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jpain.2005.03.009","volume":"6","author":"J Tang","year":"2005","unstructured":"Tang J, Gibson SJ. A psychophysical evaluation of the relationship between trait anxiety, Pain Perception, and Induced State anxiety. J Pain. 2005;6(9):612\u20139.","journal-title":"J Pain"},{"issue":"1","key":"1687_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jpainsymman.2013.08.018","volume":"48","author":"S Stiel","year":"2014","unstructured":"Stiel S, Matthies DMK, Seu\u00df D, Walsh D, Lindena G, Ostgathe C. Symptoms and problem clusters in Cancer and Non-cancer patients in Specialized Palliative Care\u2014Is there a difference? J Pain Symptom Manag. 2014;48(1):26\u201335.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"1687_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4103\/apjon.apjon_17_17","volume":"4","author":"GS \u00d6zalp","year":"2017","unstructured":"\u00d6zalp GS, Uysal N, O\u011fuz G, Ko\u00e7ak N, Karaca \u015e, Kad\u0131o\u011fullar\u0131 N. Identification of symptom clusters in cancer patients at palliative care clinic. Asia-Pacific J Oncol Nurs. 2017;4(3):259\u201364.","journal-title":"Asia-Pacific J Oncol Nurs"},{"issue":"9930","key":"1687_CR39","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721\u201330.","journal-title":"Lancet"},{"issue":"8","key":"1687_CR40","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early Palliative Care for patients with Metastatic non\u2013small-cell Lung Cancer. N Engl J Med. 2010;363(8):733\u201342.","journal-title":"N Engl J Med"},{"issue":"2","key":"1687_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40487-024-00278-3","volume":"12","author":"A-T Brenne","year":"2024","unstructured":"Brenne A-T, L\u00f8hre ET, Knudsen AK, Lund J-\u00c5, Thron\u00e6s M, Driller B, et al. Standardizing Integrated Oncology and Palliative Care Across Service levels: challenges in demonstrating effects in a prospective controlled intervention trial. Oncol Therapy. 2024;12(2):345\u201362.","journal-title":"Oncol Therapy"},{"issue":"11","key":"1687_CR42","doi-asserted-by":"publisher","first-page":"8751","DOI":"10.3390\/curroncol29110689","volume":"29","author":"V Cheng","year":"2022","unstructured":"Cheng V, Oveisi N, McTaggart-Cowan H, Loree JM, Murphy RA, De Vera MA. Colorectal Cancer and onset of anxiety and depression: a systematic review and Meta-analysis. Curr Oncol. 2022;29(11):8751\u201366.","journal-title":"Curr Oncol"},{"issue":"3","key":"1687_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/jpm.2017.0285","volume":"21","author":"R Gramling","year":"2018","unstructured":"Gramling R, Stanek S, Han PKJ, Duberstein P, Quill TE, Temel JS, et al. Distress due to prognostic uncertainty in Palliative Care: frequency, distribution, and outcomes among hospitalized patients with Advanced Cancer. J Palliat Med. 2018;21(3):315\u201321.","journal-title":"J Palliat Med"},{"issue":"3","key":"1687_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jpainsymman.2005.07.007","volume":"31","author":"AS Str\u00f6mgren","year":"2006","unstructured":"Str\u00f6mgren AS, Sjogren P, Goldschmidt D, Petersen MA, Pedersen L, Groenvold M. Symptom Priority and Course of Symptomatology in Specialized Palliative Care. J Pain Symptom Manag. 2006;31(3):199\u2013206.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"1687_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/SPC.0000000000000568","volume":"15","author":"J Sandberg","year":"2021","unstructured":"Sandberg J, Olsson M, Ekstr\u00f6m M. Underlying conditions contributing to breathlessness in the population. Curr Opin Support Palliat Care. 2021;15(4):219\u201325.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"10","key":"1687_CR46","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/jpm.2011.0109","volume":"14","author":"AH Kamal","year":"2011","unstructured":"Kamal AH, Maguire JM, Wheeler JL, Currow DC, Abernethy AP. Dyspnea Review for the Palliative Care Professional: Assessment, burdens, and etiologies. J Palliat Med. 2011;14(10):1167\u201372.","journal-title":"J Palliat Med"},{"issue":"5","key":"1687_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0885-3924(01)00278-0","volume":"21","author":"DJ Dudgeon","year":"2001","unstructured":"Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of Dyspnea in Cancer outpatients. J Pain Symptom Manag. 2001;21(5):373\u20139.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"1687_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jpainsymman.2016.08.009","volume":"53","author":"J-Y Tan","year":"2017","unstructured":"Tan J-Y, Yorke J, Harle A, Smith J, Blackhall F, Pilling M, et al. Assessment of Breathlessness in Lung Cancer: Psychometric properties of the Dyspnea-12 questionnaire. J Pain Symptom Manag. 2017;53(2):208\u201315.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"1687_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0885-3924(00)00126-3","volume":"19","author":"E Bruera","year":"2000","unstructured":"Bruera E, Schmitz B, Pither J, Neumann CM, Hanson J. The frequency and correlates of Dyspnea in patients with Advanced Cancer. J Pain Symptom Manag. 2000;19(5):357\u201362.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"1687_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamaoncol.2020.6343","volume":"7","author":"A El-Jawahri","year":"2021","unstructured":"El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb JA, Jackson VA, Campbell TC, et al. Effectiveness of Integrated Palliative and Oncology Care for patients with Acute myeloid leukemia: a Randomized Clinical Trial. JAMA Oncol. 2021;7(2):238\u201345.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1687_CR51","first-page":"149","volume":"23","author":"N Koesel","year":"2019","unstructured":"Koesel N, Tocchi C, Burke L, Yap T, Harrison A. Symptom Distress: implementation of Palliative Care guidelines to Improve Pain, fatigue, and anxiety in patients with Advanced Cancer. Clin J Oncol Nurs. 2019;23(2):149\u201355.","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"1687_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12904-023-01192-7","volume":"22","author":"Y-J Liu","year":"2023","unstructured":"Liu Y-J, Wu L-P, Wang H, Han Q, Wang S-N, Zhang J. The clinical effect evaluation of multidisciplinary collaborative team combined with palliative care model in patients with terminal cancer: a randomised controlled study. BMC Palliat Care. 2023;22(1):71.","journal-title":"BMC Palliat Care"},{"issue":"1","key":"1687_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12904-022-01121-0","volume":"21","author":"P Pornrattanakavee","year":"2022","unstructured":"Pornrattanakavee P, Srichan T, Seetalarom K, Saichaemchan S, Oer-areemitr N, Prasongsook N. Impact of interprofessional collaborative practice in palliative care on outcomes for advanced cancer inpatients in a resource-limited setting. BMC Palliat Care. 2022;21(1):229.","journal-title":"BMC Palliat Care"},{"issue":"8","key":"1687_CR54","doi-asserted-by":"publisher","first-page":"e0179415","DOI":"10.1371\/journal.pone.0179415","volume":"12","author":"S Hofmann","year":"2017","unstructured":"Hofmann S, Hess S, Klein C, Lindena G, Radbruch L, Ostgathe C. Patients in palliative care\u2014development of a predictive model for anxiety using routine data. PLoS ONE. 2017;12(8):e0179415.","journal-title":"PLoS ONE"},{"issue":"24","key":"1687_CR55","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1002\/cncr.28376","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland CS, Zhao F, Chang VT, Sloan JA, O\u2019Mara AM, Gilman PB, et al. The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013;119(24):4333\u201340.","journal-title":"Cancer"},{"issue":"2","key":"1687_CR56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1089\/jpm.2006.9.296","volume":"9","author":"E Vignaroli","year":"2006","unstructured":"Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a Screening Tool for Depression and anxiety. J Palliat Med. 2006;9(2):296\u2013303.","journal-title":"J Palliat Med"},{"issue":"3","key":"1687_CR57","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00520-013-2034-x","volume":"22","author":"CI Ripamonti","year":"2014","unstructured":"Ripamonti CI, Bandieri E, Pessi MA, Maruelli A, Buonaccorso L, Miccinesi G. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up. Support Care Cancer. 2014;22(3):783\u201393.","journal-title":"Support Care Cancer"},{"issue":"6","key":"1687_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/0269216315620082","volume":"30","author":"E Brenne","year":"2016","unstructured":"Brenne E, Loge JH, Lie H, Hjermstad MJ, Fayers PM, Kaasa S. The Edmonton Symptom Assessment System: poor performance as screener for major depression in patients with incurable cancer. Palliat Med. 2016;30(6):587\u201398.","journal-title":"Palliat Med"},{"issue":"4","key":"1687_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","volume":"50","author":"K Talari","year":"2020","unstructured":"Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020;50(4):398\u2013402.","journal-title":"J R Coll Physicians Edinb"},{"issue":"11","key":"1687_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a009758","volume":"149","author":"M Salas","year":"1999","unstructured":"Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol. 1999;149(11):981\u20133.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-025-01687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-025-01687-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-025-01687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:17:29Z","timestamp":1741846649000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-025-01687-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1186\/s12904-025-01687-5","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The Regional Committee for Medical Research Ethics, Health Region Central Norway (REK) (2018\/925\/REK Midt and 2021\/212312\/REK Midt) as healthcare improvement, without the need for explicit informed consent from the patients. Data in this study are based on a previous study and data and results are described elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}